Companies: 10,795·Total market cap: $144.5T
Syndax Pharmaceuticals, Inc.

Syndax Pharmaceuticals, Inc.

SNDXNASDAQHealthcare● Active
$16.71
$-0.63(-3.63%)
Market Cap$1.5B
P/E Ratio
52W High$25.59
52W Low$8.585
Overview

Syndax Pharmaceuticals, Inc. (SNDX) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · SNDX · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-2.80sndx eps ttm · sndx earnings per shareEarnings history
PE Ratio (TTM)sndx pe ratio ttm · sndx price to earningsPE Ratio deep dive
Revenue (TTM)$217.2Msndx revenue ttm · sndx annual revenueFull revenue history
Dividend YieldNo Dividenddoes sndx pay dividends · sndx dividend yieldDividend history
Shares Outstanding86.6Msndx shares outstanding · sndx floatShares outstanding history
Next EarningsAug 3, 2026Est.sndx earnings date · sndx next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$172.4M▲ +627.84% YoY
202320242025
syndax pharmaceuticals, inc. revenue · sndx revenue 2025
FY 2025Net Income-$285.4M▲ +10.46% YoY
202320242025
syndax pharmaceuticals, inc. net income · sndx profit 2025
FY 2025EPS$-3.29▲ +11.80% YoY
202320242025
sndx eps · syndax pharmaceuticals, inc. earnings per share 2025
TTM:Revenue: $217.2MNet Income: -$243.2MEPS: $-2.80View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy22 analystsis sndx a buy · sndx analyst rating
Strong Buy
0
Buy
20
Hold
2
Sell
0
Strong Sell
0
12-Month Price Target
$37.00Low
$16.71Current
$41.00Avg Target145.36% upside
$46.00High
sndx price target · sndx 12 month forecast

Total: 22 · Buy rate: 90.9%

The SNDX analyst consensus is Buy, based on ratings from 22 Wall Street analysts over the past 3 months. The average 12-month price target is $41.00, representing +145.36% upside from the current price of $16.71.

Stock Performance

Full History
1D-1.58%
1W-8.15%
1M-20.59%
3M-22.67%
YTD-18.77%
1Y+53.89%
5Y-12.26%

About Syndax Pharmaceuticals, Inc.

CEOMichael A. Metzger
IPO DateMar 2, 2016
Employees270
CountryUS
Websitesyndax.com

Syndax Pharmaceuticals, Inc. a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical tria…

what is syndax pharmaceuticals, inc. · sndx stock overview · syndax pharmaceuticals, inc. company profile · who is syndax pharmaceuticals, inc. ceo · sndx NASDAQ · syndax pharmaceuticals, inc. headquarters · syndax pharmaceuticals, inc. business segments

About Stock Overview & Key Data

Syndax Pharmaceuticals, Inc. (SNDX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Mar 2, 2016. As of the latest trading session, SNDX stock price is $16.71, with a market capitalization of $1.5B. The stock has returned +53.89% over the past 12 months and -18.77% year-to-date.

According to 22 Wall Street analysts, the consensus rating for Syndax Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $41.00. In fiscal year 2025, Syndax Pharmaceuticals, Inc. reported revenue of $172.4M and net income of -$285.4M. For detailed data — including Syndax Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Syndax Pharmaceuticals, Inc. (SNDX) stock price is $16.71. The stock is traded on NASDAQ under the ticker symbol SNDX. The 52-week range is $8.59 – $25.59.

SNDX stock priceSNDX quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice